Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Chengzhi Shareholding Co., Ltd. (000990.SZ)
CNY9.56
+0.40 (+4.37%)
CN SHZ Healthcare Biotechnology
Address
Huajiang Building 330013
Nanchang, CN
Nanchang, CN
CEO
Junmin Wei
Website
chengzhi.com.cn
IPO
2000-07-06
ISIN CNE0000013G2
Description
Chengzhi Shareholding Co., Ltd. engages in diverse business operations within China, encompassing clean energy, advanced functional materials, healthcare, and biotechnological fields. The company supplies specialized materials, such as liquid crystal and various chemicals essential for display technologies, alongside a range of daily and niche chemical products. Its extensive portfolio also includes edible fats and oils, a wide array of paper goods (including sanitary and household items), components for the automotive, machinery, and electronics industries, and biopharmaceutical products. Additionally, Chengzhi provides services in consulting, property management, and hospital investment management. Established in 1998, the company's main office is located in Nanchang, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY9.56
+0.40 (+4.37%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
52M
Beta
0.46
Float Shares
635.78M
Free Float %
52.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.54% | -5.62% | -25.97% | +7.64% | +27.39% | +20.96% | +23.61% | +19.15% | -28.56% | -45.26% | -2.15% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
9.56
DCF (Unlevered)
12.23
+27.9%
DCF (Levered)
16.09
+68.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2025-10 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.51
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-0.4% Q1'26: -5.4% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-133.8% Q1'26: +175.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-0.4% Q1'26: +6.3% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+2.2% ★ Q1'26: +10.2% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+1.1% ★ Q1'26: +5.5% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+0.0% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×6.56× Q1'26: 5.24× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.57B
est: 3.12B (-17.6%)
|
5.69B
est: 5.59B (+1.9%)
|
5.87B
est: 5.88B (-0.1%)
|
6.91B
est: 5.99B (+15.3%)
|
9.73B
est: 7.78B (+25.2%)
|
12.18B
est: 12.84B (-5.1%)
|
11.72B
est: 12.88B (-9.0%)
|
12.42B
est: 12.65B (-1.8%)
|
11.07B
est: 12.87B (-14.0%)
|
11.03B
est: 11.79B (-6.5%)
|
13.30B
13.30B – 13.30B
+12.8% YoY
|
14.26B
14.26B – 14.26B
+7.2% YoY
|
15.26B
15.26B – 15.26B
+7.0% YoY
|
| EBITDA |
293.49M
est: 397.78M (-26.2%)
|
1.34B
est: 711.91M (+88.6%)
|
1.43B
est: 748.21M (+91.0%)
|
1.28B
est: 763.22M (+67.1%)
|
1.38B
est: 990.13M (+39.1%)
|
2.28B
est: 1.64B (+39.2%)
|
967.02M
est: 1.64B (-41.0%)
|
1.35B
est: 1.61B (-16.4%)
|
1.30B
est: 1.49B (-12.7%)
|
909.76M
est: 1.36B (-33.2%)
|
1.54B
1.54B – 1.54B
+12.8% YoY
|
1.65B
1.65B – 1.65B
+7.2% YoY
|
1.76B
1.76B – 1.76B
+7.0% YoY
|
| EBIT |
149.20M
est: 231.96M (-35.7%)
|
890.58M
est: 415.13M (+114.5%)
|
981.02M
est: 436.30M (+124.9%)
|
780.63M
est: 445.05M (+75.4%)
|
755.70M
est: 577.37M (+30.9%)
|
1.66B
est: 953.59M (+73.7%)
|
374.18M
est: 956.34M (-60.9%)
|
757.78M
est: 939.34M (-19.3%)
|
716.08M
est: 813.09M (-11.9%)
|
246.60M
est: 745.22M (-66.9%)
|
840.32M
840.32M – 840.32M
+12.8% YoY
|
900.80M
900.80M – 900.80M
+7.2% YoY
|
964.21M
964.21M – 964.21M
+7.0% YoY
|
| Net Income |
110.78M
est: 24.30M (+355.8%)
|
808.51M
est: 802.06M (+0.8%)
|
849.32M
est: 911.43M (-6.8%)
|
442.55M
est: 559.01M (-20.8%)
|
355.08M
est: 206.59M (+71.9%)
|
1.01B
est: 1.37B (-26.6%)
|
50.93M
est: 376.72M (-86.5%)
|
177.40M
est: 437.49M (-59.4%)
|
230.59M
est: 291.67M (-20.9%)
|
-78.14M
est: 72.92M (-207.2%)
|
723.09M
723.09M – 723.09M
+891.7% YoY
|
875.00M
875.00M – 875.00M
+21.0% YoY
|
1.01B
1.01B – 1.01B
+15.3% YoY
|
| SGA |
339.82M
est: 150.57M (+125.7%)
|
434.87M
est: 269.47M (+61.4%)
|
439.17M
est: 283.21M (+55.1%)
|
541.54M
est: 288.89M (+87.5%)
|
515.54M
est: 374.78M (+37.6%)
|
564.95M
est: 618.99M (-8.7%)
|
564.34M
est: 620.77M (-9.1%)
|
507.86M
est: 609.73M (-16.7%)
|
581.83M
est: 516.77M (+12.6%)
|
141.21M
est: 473.64M (-70.2%)
|
534.08M
534.08M – 534.08M
+12.8% YoY
|
572.52M
572.52M – 572.52M
+7.2% YoY
|
612.82M
612.82M – 612.82M
+7.0% YoY
|
| EPS |
0.29
est: 0.02 (+1,350.0%)
|
0.65
est: 0.66 (-1.5%)
|
0.69
est: 0.75 (-8.0%)
|
0.36
est: 0.46 (-20.8%)
|
0.29
est: 0.17 (+71.9%)
|
0.83
est: 1.13 (-26.5%)
|
0.04
est: 0.31 (-86.5%)
|
0.15
est: 0.36 (-59.4%)
|
0.19
est: 0.24 (-20.8%)
|
-0.06
est: 0.06 (-207.2%)
|
0.60
0.60 – 0.60
+891.7% YoY
|
0.72
0.72 – 0.72
+21.0% YoY
|
0.83
0.83 – 0.83
+15.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B- | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-129.68M
OE per share TTM
-0.11
Owner's Yield
-1.11%
Maintenance CapEx ratio
96.47%
Maint CapEx / Avg PPE
56.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 22 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 88.2K | 0.65% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 102.1K | 0.46% |
| 3 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 28.5K | 0.44% |
| 4 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 431.6K | 0.06% |
| 5 | Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating V3AA.L | 0.00% | 50.1K | 0.24% |
| 6 | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing V3AL.L | 0.00% | 50.1K | 0.24% |
| 7 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 158.6K | 0.39% |
| 8 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 20.9K | 0.48% |
| 9 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 47.2K | 0.26% |
| 10 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 2.33M | 0.06% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
58.8K
Shares Outstanding
1.22B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bao Jian Qin | Vice President | — | male |
| Jin Liang | Chief Financial Officer | — | male |
| Junmin Wei | President & Non-Independent Director | — | male |
| Lianyan Jiang | Vice President | — | female |
| Rui Li | Vice President & Non-Independent Director | — | male |
| Tan Bin | Vice President | — | male |
| Xin Wang | Vice President | — | female |
| Yong Hua Zou | Executive Vice President & Human Resources Director | — | male |
| Zuo Hao | Vice President & Secretary of the Board | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 000990.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
